Ethyl 4-hydroxyquinoline-2-carboxylate, 95.0%, 250mg

Y-320>98.0%(HPLC)5mg

2-(Pyrrolidin-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinonitrile, 95.0%, 1g

tert-Butyl 5-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine-1-carboxylate, 98%, 250mg

({[1,1'-biphenyl]-4-yl}methyl)(prop-2-en-1-yl)amine, 95.0%, 10g

4-(Aminomethyl)-5-(hydroxymethyl)-2-methylpyridin-3-ol dihydrochloride, 95.0%, 100g

4-(Chloromethyl)-2-methoxy-6-methylpyridine, 97.0%, 100mg

2-[2-(3-CHLOROPHENYL)ETHYL]-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE, 97.0%, 250mg

(S)-1-(Cyclopropylmethyl)pyrrolidin-3-amine dihydrochloride, 95.0%, 1g

(2R)-2-AMINO-2-(4-METHYLPHENYL)ETHAN-1-OL, 95.0%, 1g

3-Acetyl-2-methylbenzonitrile, 250mg

1-[(6-AMINOHEXYL)SULFANYL]ETHAN-1-ONE HYDROCHLORIDE, 95%, 250mg

Piperazine, 1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenyl-2-propen-1-yl]-, hydrochloride (1:2), 99%, 25g